Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718 – The Herald | HeraldOnline.com (press release)
|
Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718
The Herald | HeraldOnline.com (press release) CAMBRIDGE, Mass. — Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard … |
